8-K: Intelligent Bio Solutions Highlights Growing Demand for Drug Testing in Key Industries

Intelligent Bio Solutions Inc. emphasizes the increasing need for drug testing solutions across critical sectors due to rising on-the-job drug use.

Summary

• Intelligent Bio Solutions Inc. released a press release on August 13, 2024, highlighting the growing need for drug testing solutions in industries such as construction, manufacturing, transport, warehousing, mining, and automotive.
• The company cites a 2023 survey indicating that 17.8% of adults in the U.S. used illicit drugs in the past month.
• A 2015 report showed that 8.6% of full-time workers aged 18 to 64 used illicit drugs in the past month.
• A 2017 survey revealed that 7 in 10 employers have experienced the effects of prescription drug misuse, with 71% considering it a disease.
• Drug use rates vary by industry, with construction at 11.6%, manufacturing at 7.4%, and transportation and warehousing at 5.9% based on data from 2008 to 2012.
• A 2019 analysis found that 27.6% of truck drivers consumed drugs.
• A study by the National Highway Safety Administration showed that 22.3% of daytime drivers and 22.5% of nighttime drivers tested positive for drugs.
• Intelligent Bio Solutions believes its non-invasive drug testing system is well-positioned to meet this growing demand.
• The company plans to provide additional insights in the coming weeks leading up to the filing of their Annual Report on Form 10-K and upcoming earnings release.

Sentiment

Score: 7

Explanation: The document presents a positive outlook on the company's growth potential due to the increasing demand for drug testing solutions, but also acknowledges the risks associated with commercialization and regulatory approvals.

Positives

• The company is addressing a clear and growing market need for drug testing solutions.
• Intelligent Bio Solutions' non-invasive drug testing system is positioned to capitalize on the increasing demand.
• The company is expanding into new markets and gaining new accounts.
• The company plans to provide additional insights in the coming weeks leading up to the filing of their Annual Report on Form 10-K and upcoming earnings release.

Risks

• The company's ability to successfully develop and commercialize its drug and diagnostic tests is subject to risks and uncertainties.
• Realizing commercial benefits from partnerships and collaborations is not guaranteed.
• Securing regulatory approvals is also subject to risks and uncertainties.

Future Outlook

The company plans to provide additional insights in the coming weeks leading up to the filing of their Annual Report on Form 10-K and upcoming earnings release. The company is focused on expanding into new markets and gaining new accounts.

Management Comments

• Intelligent Bio Solutions believes that our company is positioned to lead the way in providing innovative, non-invasive drug testing technologies.
• Our Intelligent Fingerprinting Drug Screening System is designed to offer a non-invasive, efficient, and reliable method for employers to safeguard their workforce.

Industry Context

The announcement highlights the growing concern about drug use in various industries, aligning with broader trends emphasizing workplace safety and productivity. The company is positioning itself to capitalize on the increasing demand for effective drug testing solutions.

Comparison to Industry Standards

• The document cites various studies and reports from organizations like SAMHSA, National Safety Council, and NHTSA, which are standard benchmarks for understanding drug use trends.
• The reported drug use percentages in specific industries like construction (11.6%) and transportation (5.9%) are consistent with industry-wide concerns about substance abuse in these sectors.
• The 27.6% drug use rate among truck drivers is a significant concern, and the company is positioning itself to address this specific issue.
• The 22% drug positivity rate among drivers is also a significant concern and is consistent with other studies in the industry.

Stakeholder Impact

• Shareholders may view the company's growth prospects positively.
• Employees may benefit from a safer work environment.
• Customers (employers) will have access to a non-invasive drug testing solution.
• Suppliers may see increased demand for related products and services.

Next Steps

• The company plans to provide additional insights in the coming weeks leading up to the filing of their Annual Report on Form 10-K.
• The company will also have an upcoming earnings release.

Key Dates

Keywords

drug testing, drug screening, illicit drug use, prescription drug misuse, workplace safety, non-invasive testing, Intelligent Bio Solutions, INBS